A clinical study to compare the effects of nitrofurantoin and extract form of Unani drugs in the treatment of E.coli induced Urinary Tract Infection.
Phase 2
- Conditions
- Health Condition 1: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2022/04/041663
- Lead Sponsor
- Ayurvedic and Unani Tibbia College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient between the age of 18 to 65 years of either sex.
Diagnosed patient of E. coli induced UTI (by urine culture & sensitivity).
Patients willing to participate and sign the understood, informed consent form.
Patient willing to discontinue the drugs taking for the treatment of UTI.
Exclusion Criteria
Patients with any anatomical abnormality of urinary tract.
Patient with Diabetes Mellitus.
Patient with Hepatic & Renal insufficiency and malignancy.
Pregnant and lactating women.
Resistant to the standard control drug
Patient unwilling to sign the consent form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To develop a safe efficacious and cost effective drug from a herbal source for the management of Urinary Tract Infection Tadiya e Majra e Baul caused by E coli <br/ ><br>To evaluate the safety and efficacy of the proposed Unani Polyherbal <br/ ><br>Formulation in the treatment of Urinary Tract Infection Tadiya e Majra e Baul caused by E coli <br/ ><br>To compare the results of polyherbal unani formulation from standard control drug in respect of safety and efficacy in the treatment of UTI <br/ ><br>Timepoint: 30 Days
- Secondary Outcome Measures
Name Time Method To evaluate the improvement of quality of life in test group patientsTimepoint: 30 Days